Frutarom will acquire full ownership of Enzymotec, Israel for US$210 million.###The merger will enable full integration of the companies’ activities in the fields of R&D, sales, marketing, production, supply chacitrate 1000 mg tabletin and logistics.###It will also accelerate ferrous fumarate is ironjoint growth through cross-selling opportunities inherent in the acquisition and the expansion of the product portfolio to bomagnesium citrate magnesium oxideth companies’ existing customer bases. ###Frutarom sees Enzymotec’s nutfe fumaraterition segment as playing an important part in its growth and expansion of solutions in the fields ofcalcium magnesium citrate with vitamin d pharmaceuticals, dietary supplements, designated foods for infants in the field of infant formula (where Frutarom has almost no activity currently) and elderly clinical nutrition in which Frutarom is active.